Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Characterising protein oligomers and their role in neurodegenerative disease in humans

Ziel

Small soluble protein aggregates play a key role in the onset and spreading of Alzheimer’s and Parkinson’s diseases. However, which oligomers are present in human disease and which are toxic remains unknown because ultrasensitive methods do not exist to detect and characterise the low concentration of oligomers, which are highly heterogeneous in size and structure. To address this problem we will develop fluorescence based methods to detect and characterise individual oligomers to measure the oligomer size, structure, proteinase K resistance, seeding capability and composition. We will also develop methods to enrich these oligomers so we can use mass spectrometry to determine post translational modifications and recover the oligomers to directly test their cytotoxicity and mechanism of damage. The capability to characterise these oligomers at this unprecedented level of detail will represent a major advance in the field. These methods will then be applied to stem cell models of Alzheimer’s disease and Parkinson’s disease and then clinical samples of CSF from patients. These experiments will determine how the number, composition or structure of the oligomers changes in the disease and if this results in increased cytotoxicity. Clinical samples of CSF from patients with genetic mutations will be used to determine if detectable changes in the oligomers occur early in the disease and samples of brain tissue used to determine the changes in oligomers during the spreading of the disease.

By the end of the project we will have determined which oligomers play major roles in the onset and spreading of Alzheimer’s and Parkinson’s disease in humans, providing targets for therapies, and tested if the detection and characterisation of these oligomers can be used for early diagnosis of the disease.

Wissenschaftliches Gebiet (EuroSciVoc)

Programm/Programme

Thema/Themen

Finanzierungsplan

ERC-ADG - Advanced Grant

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) ERC-2014-ADG

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Gastgebende Einrichtung

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Netto-EU-Beitrag
€ 2 499 551,00
Adresse
TRINITY LANE THE OLD SCHOOLS
CB2 1TN CAMBRIDGE
Vereinigtes Königreich
Region
East of England East Anglia Cambridgeshire CC
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
€ 2 499 551,00

Begünstigte (1)